Zeqi Niu

机构：Hunan University, Hunan University of Science and Engineering, University of Michigan, AbbVie (United States), BC Platforms (Finland), BioSurfaces (United States), Shandong First Medical University, College of Business Administration · ORCID：0000-0002-9025-616X

发表论文 19 篇 · 总被引 183 次 · h-index 6

代表论文

• On‐Chip Biogenesis of Circulating NK Cell‐Derived Exosomes in Non‐Small Cell Lung Cancer Exhibits Antitumoral Activity (2021 · Advanced Science · 被引 103)
• Circulating tumor cells reveal early predictors of disease progression in patients with stage III NSCLC undergoing chemoradiation and immunotherapy (2024 · Cell Reports · 被引 16)
• OA09.03 Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC) (2021 · Journal of Thoracic Oncology · 被引 16)
• It’s not ‘just a tube of blood’: principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies (2021 · Journal for ImmunoTherapy of Cancer · 被引 16)
• Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics (2024 · Neoplasia · 被引 11)
• In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation (2025 · Journal of the American Chemical Society · 被引 7)